A Study of the Effects of a New Antidepressant Treatment (GSK561679) in Females With Major Depressive Disorder
Status:
Completed
Trial end date:
2010-06-18
Target enrollment:
Participant gender:
Summary
This six-week study will evaluate the efficacy, safety and tolerability of GSK561679 compared
to placebo in female subjects with major depressive disorder